Crossmark

A case of successful treatment with lenvatinib in primary hepatoid adenocarcinoma of the gallbladder that was difficult to distinguish from hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1007/s12328-022-01686-6

Published Online: 2022-08-24

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Iwasaki, Shuichiro

Hidaka, Hisashi https://orcid.org/0000-0002-4151-5663
Uojima, Haruki

Kubo, Hidefumi

Adachi, Kai

Wada, Naohisa

Kubota, Kousuke

Nakazawa, Takahide

Shibuya, Akitaka

Kusano, Chika
License Information

Text and Data Mining valid from 2022-08-24

Version of Record valid from 2022-08-24
More Information

Article History

Received: 12 January 2022

Accepted: 1 August 2022

First Online: 24 August 2022

Declarations

:

: The authors declare that they have no conflicts of interest.

: This case report follows the precepts of the Declaration of Helsinki.

: Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Document is current

Any future updates will be listed below